Limitless Life Nootropics
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Limitless Life Nootropics between 13 Feb 2025 and 19 Feb 2025. Tests score average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Limitless Life Nootropics
Retatrutide
Tested 4 Samples
Last test 19 Feb 2025
Take Action
Mail in a Sample
We test your peptides for free: mail in a sample you have (US only), or request us to test a vendor.
Retatrutide is also available from top-rated vendors:
All Retatrutide tests from Limitless Life Nootropics
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
19 Feb 2025
First
13 Feb 2025
| Quantity | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Test Date | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 19 Feb 2025 | 6mg | 6.250mg | +4.2% | 99.95% | 1220 | White Label / Red Cap | Lab B | Finnrick | |
| 14 Feb 2025 | 6mg | 4.437mg | -26.1% | 99.68% | 1220 | White Label / Red Cap | Lab A | Finnrick | |
| 13 Feb 2025 | 6mg | 5.635mg | -6.1% | 98.48% | 1220 | White Label / Red Cap | Lab C | Finnrick | |
| 13 Feb 2025 | 6mg | 5.167mg | -13.9% | 98.98% | 1220 | White Label / Red Cap | Lab C | Finnrick | |
Corrections
- 15 Apr 2025
- Lab B test 19 Feb 2025: updated quantity following the identification of a clerical error, value was erroneously listed as 9.27mg. Lab issued an updated test certificate on 7 Apr 2025.